Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
CCR4 与 CCR7 对胸腺细胞定位和中枢耐受的独特贡献
基本信息
- 批准号:10411920
- 负责人:
- 金额:$ 47.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-03-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AgonistAntigen ReceptorsAntigen-Presenting CellsAntigensAutoantigensAutoimmunityAutomobile DrivingBiological AssayBloodBone MarrowCC chemokine receptor 4CD69 antigenCell SurvivalCellsChimera organismDangerousnessDataDendritic CellsEnsureFundingGeneticImpairmentIndividualLifeLigandsMalignant NeoplasmsMature ThymocyteMediatingModelingMolecularMosaicismPeripheralPlayProcessProteinsProteomeRegulatory T-LymphocyteReportingRoleScanningSelf ToleranceStructure of thymic medullaT cell receptor repertoire sequencingT-LymphocyteT-cell receptor repertoireTestingThymic epithelial cellThymocyte SelectionThymus GlandTissuesautoreactive T cellautoreactivitybasecentral tolerancechemokine receptorcombatdifferential expressionexperimental studyinnovationmouse modelnovelpathogenpreventreceptor expressionthymocytetwo photon microscopy
项目摘要
ABSTRACT
After undergoing positive selection in the cortex, thymocytes migrate into the medulla where central
tolerance is enforced by antigen presenting cells (APCs) displaying a diverse array of auto-antigens. Dendritic
cells (DCs) and medullary thymic epithelial cells (mTECs) are the two predominant medullary APCs that induce
central tolerance. Collectively, mTECs express the majority of the proteome, but any individual self- antigen is
expressed by only 1-3 % of these cells. Thymic DCs present self-antigens derived not only from their own
proteome, but also those acquired from the blood, from mTECs, and from peripheral tissues. Thus, mTECs
and DCs display a mosaic of self-antigens, which thymocytes must navigate to scan for auto-reactivity. This
process is critical for self-tolerance, as lost expression of even one self-antigen in the thymus can result in
peripheral autoimmunity. In this proposal, we will investigate mechanisms by which the chemokine receptors
CCR4 and CCR7 alter thymocyte localization and interactions with distinct APCs to enforce central tolerance.
It is well-documented that CCR7 promotes thymocyte medullary localization and thus, negative
selection. Over the last funding period, we identified a critical role for CCR4 in these processes as well. Our
data suggest a novel model in which CCR4 promotes medullary entry of post-positive selection thymocytes
and interactions with DCs, while CCR7 sustains medullary localization of mature thymocytes and promotes
interactions mTECs, to induce negative selection and Treg differentiation of distinct TCR repertoires. In Aim 1,
we will use a combination of 2-photon microscopy, TCR repertoire sequencing, and TCR retrogenic bone
marrow chimeras to test the impact of CCR4 and CCR7 on thymocyte localization, interactions with APCs, and
central tolerance. Notably, we have developed a novel 2-photon microscopy approach to quantify the
contribution of distinct APCs to negative selection, and will expand this approach to identify APCs required for
Treg selection. Our recent data also suggest that both early and late stages of negative selection occur in the
medulla, driven by CCR4 and CCR7, respectively. In Aim 2, we will test this novel model, which contrasts with
the prevailing view that early and late stages of selection occur in the cortex and medulla, respectively. Over
the last funding period, we identified a novel role for CCR7 expression by thymic DCs in regulating Treg
selection. In Aim 3, we will use existing and novel genetic mouse models, functional assays, TCR repertoire
sequencing, and retrogenic bone marrow chimeras to test the hypothesis that CCR7 expression by thymic DCs
promotes their survival and is required for acquisition and display of mTEC-derived self-antigens, thus
impacting repertoire selection. Altogether, the proposed experiments will elucidate mechanisms by which
CCR4 and CCR7 promote central tolerance and will test the innovative model, suggested by our data, that
central tolerance is separated into two stages, first dominated by DC-mediated deletion of less mature
thymocytes, and then by mTEC-mediated deletion of mature thymocytes to ensure self- tolerance.
摘要
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dynein Separately Partners with NDE1 and Dynactin To Orchestrate T Cell Focused Secretion.
- DOI:10.4049/jimmunol.1600180
- 发表时间:2016-09-15
- 期刊:
- 影响因子:0
- 作者:Nath S;Christian L;Tan SY;Ki S;Ehrlich LI;Poenie M
- 通讯作者:Poenie M
Chemokine-Mediated Choreography of Thymocyte Development and Selection.
- DOI:10.1016/j.it.2017.10.007
- 发表时间:2018-03
- 期刊:
- 影响因子:16.8
- 作者:Lancaster JN;Li Y;Ehrlich LIR
- 通讯作者:Ehrlich LIR
EBI2 contributes to the induction of thymic central tolerance in mice by promoting rapid motility of medullary thymocytes.
EBI2 通过促进髓质胸腺细胞的快速运动,有助于诱导小鼠胸腺中枢耐受。
- DOI:10.1002/eji.201747020
- 发表时间:2017
- 期刊:
- 影响因子:5.4
- 作者:Ki,Sanghee;Thyagarajan,HiranM;Hu,Zicheng;Lancaster,JessicaN;Ehrlich,LaurenIR
- 通讯作者:Ehrlich,LaurenIR
CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction.
CCR8 由阳性选择后 CD4 谱系胸腺细胞表达,但对于中枢耐受诱导来说是可有可无的。
- DOI:10.1371/journal.pone.0200765
- 发表时间:2018
- 期刊:
- 影响因子:3.7
- 作者:Thyagarajan,HiranM;Lancaster,JessicaN;Lira,SergioA;Ehrlich,LaurenIR
- 通讯作者:Ehrlich,LaurenIR
Detecting T Cell Activation Using a Varying Dimension Bayesian Model.
- DOI:10.1080/02664763.2017.1290789
- 发表时间:2018
- 期刊:
- 影响因子:1.5
- 作者:Hu Z;Lancaster JN;Ehrlich LIR;Müller P
- 通讯作者:Müller P
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Ilyse Richie EHRLICH其他文献
Lauren Ilyse Richie EHRLICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren Ilyse Richie EHRLICH', 18)}}的其他基金
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
CCR4 与 CCR7 对胸腺细胞定位和中枢耐受的独特贡献
- 批准号:
10200461 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10022939 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10251300 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10470932 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10689304 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Role of the microenvironment in regulating early stages of thymic involution and central tolerance
微环境在调节胸腺复旧和中枢耐受早期阶段的作用
- 批准号:
10553994 - 财政年份:2017
- 资助金额:
$ 47.22万 - 项目类别:
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
CCR4 与 CCR7 对胸腺细胞定位和中枢耐受的独特贡献
- 批准号:
10265640 - 财政年份:2014
- 资助金额:
$ 47.22万 - 项目类别:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
GPCR 对胸腺细胞髓质进入和中枢耐受的贡献
- 批准号:
8820882 - 财政年份:2014
- 资助金额:
$ 47.22万 - 项目类别:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
GPCR 对胸腺细胞髓质进入和中枢耐受的贡献
- 批准号:
9011993 - 财政年份:2014
- 资助金额:
$ 47.22万 - 项目类别:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
GPCR 对胸腺细胞髓质进入和中枢耐受的贡献
- 批准号:
9230336 - 财政年份:2014
- 资助金额:
$ 47.22万 - 项目类别:
相似海外基金
Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
- 批准号:
23K06728 - 财政年份:2023
- 资助金额:
$ 47.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
- 批准号:
2145853 - 财政年份:2022
- 资助金额:
$ 47.22万 - 项目类别:
Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
- 批准号:
22K06603 - 财政年份:2022
- 资助金额:
$ 47.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
- 批准号:
MR/W031353/1 - 财政年份:2022
- 资助金额:
$ 47.22万 - 项目类别:
Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10701754 - 财政年份:2022
- 资助金额:
$ 47.22万 - 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10557760 - 财政年份:2022
- 资助金额:
$ 47.22万 - 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
- 批准号:
437200 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
- 批准号:
20H03536 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10542442 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
9922602 - 财政年份:2020
- 资助金额:
$ 47.22万 - 项目类别:














{{item.name}}会员




